Oncology & Cancer

In first for EU, anti-skin cancer drug approved

French pharmaceutical giant Sanofi on Friday said the European Medicines Agency had conditionally approved its anti-cancer drug Libtayo, the first drug of its kind to be authorised for use in the EU.

Other

Single topical ivermectin head lice treatment very effective

(HealthDay)—A single 10-minute, at-home treatment with topical ivermectin lotion eliminates head lice infestations in nearly all patients by the next day, according to a study published in the Nov. 1 issue of the New England ...

Other

Sanofi to buy US biotech firm Amunix for $1 bn

French pharma giant Sanofi said Tuesday it had signed a billion-dollar deal to buy US-based biotech firm Amunix, which develops cancer treatments that enlist the body's immune system.

Diseases, Conditions, Syndromes

UGA, Sanofi Pasteur develop new vaccine for H1N1 influenza

Researchers at the University of Georgia and Sanofi Pasteur, the vaccines division of Sanofi, announced today the development of a vaccine that protects against multiple strains of both seasonal and pandemic H1N1 influenza ...

page 1 from 13